We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
Cap. Flow
-$1.26B
Cap. Flow %
-1.13%
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73

Top Buys

Rank Stock Value
1
EXE
Expand Energy Corp
EXE
+$56.7M
2
APO icon
Apollo Global Management
APO
+$36.8M
3
BA icon
Boeing
BA
+$34.1M
4
WDAY icon
Workday
WDAY
+$31.9M
5
DOCU
DocuSign
DOCU
+$26.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$136M
2
NVDA icon
NVIDIA
NVDA
+$110M
3
MSFT icon
Microsoft
MSFT
+$84.1M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$48.4M
5
XYZ
Block Inc
XYZ
+$44.9M

Sector Composition

Rank Sector Weight
1 Technology 30.97%
2 Financials 13.53%
3 Consumer Discretionary 11.77%
4 Healthcare 10.06%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EP icon
3126
Empire Petroleum
EP
$111M
$132K ﹤0.01%
17,384
XPEV icon
3127
XPeng
XPEV
$11.6B
$132K ﹤0.01%
11,164
+14
+0.1% +$173
INFU icon
3128
InfuSystem Holdings
INFU
$249M
$132K ﹤0.01%
15,611
-1,163
-7% -$9.17K
GEOS icon
3129
Geospace Technologies
GEOS
$75.7M
$132K ﹤0.01%
13,137
+320
+2% +$3.56K
XFOR icon
3130
X4 Pharmaceuticals
XFOR
$460M
$131K ﹤0.01%
5,958
+9
+0.2% +$143
IWN icon
3131
iShares Russell 2000 Value ETF
IWN
$14.6B
$131K ﹤0.01%
799
-517
-39% -$88.2K
ARTV
3132
Artiva Biotherapeutics
ARTV
$551M
$130K ﹤0.01%
12,879
-1,950
-13% -$23.4K
CTGO icon
3133
Contango Silver & Gold Inc
CTGO
$652M
$130K ﹤0.01%
12,944
-193
-1% -$3.28K
VIK icon
3134
Viking Holdings
VIK
$47.2B
$130K ﹤0.01%
+2,940
New +$125K
QIPT
3135
DELISTED
Quipt Home Medical
QIPT
$128K ﹤0.01%
41,879
+904
+2% +$2.43K
GRFS
3136
Grifois
GRFS
$5.4B
$127K ﹤0.01%
17,122
MNSO icon
3137
MINISO
MNSO
$3.75B
$127K ﹤0.01%
5,301
-5
-0.1% -$101
ZK
3138
DELISTED
Zeekr
ZK
$126K ﹤0.01%
4,449
+29
+0.7% +$738
GYRE icon
3139
Gyre Therapeutics
GYRE
$744M
$126K ﹤0.01%
10,432
+8
+0.1% +$102
UP icon
3140
Wheels Up
UP
$198M
$126K ﹤0.01%
3,824
-286
-7% -$12K
OEF icon
3141
iShares S&P 100 ETF
OEF
$20.6B
$125K ﹤0.01%
433
+200
+86% +$57.2K
RILY icon
3142
BRC Group Holdings
RILY
$289M
$124K ﹤0.01%
27,099
-2,068
-7% -$10.8K
SLF icon
3143
Sun Life Financial
SLF
$45.4B
$124K ﹤0.01%
2,082
-7
-0.3% -$413
INDY icon
3144
iShares S&P India Nifty 50 Index Fund
INDY
$569M
$124K ﹤0.01%
2,430
NAUT icon
3145
Nautilus Biotechnolgy
NAUT
$115M
$123K ﹤0.01%
73,383
+2,497
+4% +$5.97K
CAAP icon
3146
Corporacion America
CAAP
$4.09B
$123K ﹤0.01%
6,600
+500
+8% +$9.4K
FNV icon
3147
Franco-Nevada
FNV
$46B
$123K ﹤0.01%
1,047
-103
-9% -$12.7K
CVGI icon
3148
Commercial Vehicle Group
CVGI
$147M
$123K ﹤0.01%
49,611
+2,333
+5% +$6.23K
OBIO icon
3149
Orchestra BioMed
OBIO
$254M
$123K ﹤0.01%
30,743
+1,196
+4% +$6.42K
WFG icon
3150
West Fraser Timber
WFG
$5.65B
$123K ﹤0.01%
1,420

Similar funds

RhumbLine Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
  • RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
  • RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
  • RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
  • RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
  • RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.

Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.